Search Results - "Birkegård, C."

5613081 GAPS IN DATA ON GLOBAL PREVALENCE AND BIRTH PREVALENCE OF SICKLE CELL DISEASE AND SICKLE CELL TRAIT: CALL FOR ACTION TO SCALE UP AND HARMONIZE DATA COLLECTION by Colombatti, R., Hegemann, I., Medici, M., Birkegård, C.

Get full text

PB2215: GLOBAL EPIDEMIOLOGY OF SICKLE CELL DISEASE: A SYSTEMATIC LITERATURE REVIEW by Colombatti, R., Birkegård, C., Medici, M.

Get full text

Predicting effects of changed antimicrobial usage on the abundance of antimicrobial resistance genes in finisher’ gut microbiomes by Andersen, V.D., Aarestrup, F.M., Munk, P., Jensen, M.S., de Knegt, L.V., Bortolaia, V., Knudsen, B.E., Lukjancenko, O., Birkegård, A.C., Vigre, H.

“…It is accepted that usage of antimicrobials (AMs) in food animals causes the emergence and spread of antimicrobial resistance (AMR) in this sector, while also…”
Get full text

Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8‐ to 10‐Year Period by Birkegård, A.C., Reimann, M.J., Martinussen, T., Häggström, J., Pedersen, H.D., Olsen, L.H.

“…BACKGROUND: Cavalier King Charles Spaniels (CKCS) are predisposed to myxomatous mitral valve disease (MMVD). Studies have indicated a strong genetic…”
Get full text

Spatial patterns of antimicrobial resistance genes in a cross-sectional sample of pig farms with indoor non-organic production of finishers by BIRKEGÅRD, A. C., ERSBØLL, A. K., HALASA, T., CLASEN, J., FOLKESSON, A., VIGRE, H., TOFT, N.

“…Antimicrobial resistance (AMR) in pig populations is a public health concern. There is a lack of information of spatial distributions of AMR genes in pig…”
Get full text

PDB82 Development of a Novel Algorithm to Identify Individuals with Possible Adult Growth Hormone Deficiency from a US Administrative Claims Database by Birkegård, C., Blevins, L.S., Clemmons, D.R., Fleseriu, M., Hoffman, A.R., Kerr, J.M., Sun, T., Tarp, J., Tritos, N.A., Yuen, K.

Get full text

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program by Biller, Beverly M. K., Höybye, Charlotte, Carroll, Paul, Gordon, Murray B., Birkegård, Anna Camilla, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias M.

“…Purpose Data on the safety of growth hormone (GH) replacement therapy during pregnancy are limited. We report a combined analysis of data from pregnant women…”
Get full text